Zensar Technologies (504067) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
9 Aug, 2026Executive summary
Q1 FY27 revenue reached $159.5 million (₹15,083 million), up 1.1% sequentially and 8.9% YoY in INR terms, with BFSI driving growth and AI transformation a strategic focus.
PAT margin was 12.2%, down 220 basis points sequentially, with net profit at ₹1,838 million.
Order book stood at $149.2 million, up 62.9% QoQ, and cash balance was $317.5 million.
Attrition rate improved to 9.6% for the sixth consecutive quarter.
Recognized as India's #1 IT Services company to work for in 2026.
Financial highlights
EBITDA margin contracted by 150 basis points sequentially to 14.6% due to pre-staffing, transition costs, and increased travel, visa, and training expenses.
Diluted EPS was INR 8 per share, up 0.9% YoY; basic EPS was ₹8.11.
Top 5 clients contributed 24.7% of revenue, top 10 clients 38.9%, and top 20 clients 56.6%.
Total assets as of June 30, 2026, were ₹61,839 million.
OCF to EBITDA conversion above 70%; DSO at 75 days.
Outlook and guidance
Full revenue impact from the $210 million mega BFSI deal expected in Q3 and Q4, with continued ramp-up in Q2.
Margins expected to remain at Q1 levels for Q2 and Q3 due to ongoing investments in SG&A, AI, and large deal ramp-up.
Q2 anticipated to be better than Q1, with growth momentum expected to continue.
No further impact from Labour Code changes is expected.
Management emphasizes expanding enterprise AI adoption and cloud modernization.
Latest events from Zensar Technologies
- AI-driven growth, robust financials, and ESG leadership marked FY26 performance.504067
Investor presentation - Record order book and profit growth in FY26, with final dividend of ₹12.60 per share recommended.504067
Q4 25/26 - Q3 FY26 saw revenue and margin growth, strong order book, and continued AI-driven investments.504067
Q3 25/26 - Q2 revenue up 4.2% YoY to $162.8M, with margin gains, AI momentum, and TMT headwinds.504067
Q2 25/26 - Record order book, stable margins, and strong BFSI/healthcare growth; BridgeView acquired.504067
Q2 24/25 - Q3 FY25 revenue up 8.6% YoY to $157.0M, with 15.6% EBITDA margin and record order book.504067
Q3 24/25 - Q4 FY25 saw 6.3% YoY revenue growth, higher PAT margin, strong order book, and increased dividends.504067
Q4 24/25 - Q1 FY26 revenue up 4.9% YoY to $162M, with strong AI and digital/cloud growth but margin pressures.504067
Q1 25/26